Rob Nunes

Rob Nunes is a scientist at Moderna, with a focus on method transfer, innovation, and automation to enhance analytical and high-throughput operational testing since November 2021. Previously serving as Principal Research Associate and Team Lead at Dewpoint Therapeutics, Rob Nunes developed and optimized assays to facilitate drug discovery through condensate biology. Experience also includes roles as Sr. Research Associate at TIAKI Therapeutics and Associate Scientist positions at BioLegend and Cell Signaling Technology, where Rob Nunes developed and validated antibodies, managed mammalian cell cultures, and collaborated across departments. Education includes a Bachelor's Degree in Chemistry with a Biochemistry concentration from Salem State University, completed in 2008.